Part 4: Systems of Care and Continuous Quality Improvement: 2015 Guidelines Update Writing Group Disclosures
Writing Group Member Employment Research Grant Other Research Support Speakers’ Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other
Steven L. Kronick University of Michigan None None None None None None None
Robert A. Berg Children’s Hospital of Philadelphia None None None None None None None
John E. Billi The University of Michigan Medical School None None None None None None None
Jose G. Cabanas City of Austin None None None None None None None
David C. Cone Yale University School of Medicine None None None None None None None
Deborah B. Diercks University of California Davis Medical Center Astra Zeneca*; PCORI* None None None None None Society of Cardiovascular Patient Care*
Dana P. Edelson University of Chicago American Heart Association/Laerdal Medical†; NIH† None None None QuantHC†; Patent Pending ARCD. P0535US.P2† None None
James (Jim) Foster University of Alaska None None None None None None None
Michael C. Kurz University of Alabama at Birmingham NIH†; RPS* None Zoll Medical Corporation* None None None None
Steve Lin Li Ka Shing Knowledge Institute of St. Michael’s Hospital Canadian Institutes None of Health Research†;
Academic Health Sciences Centre (AHSC) Alternative Funding Plan Innovation Fund†; Physicians’ Services Incorporated (PSI) Foundation†; Canadian Association
of Emergency Physicians*
None None None None None None
Reylon A. Meeks Blank Children’s Hospital None None None None None None None
Michelle Welsford Centre for Paramedic Education and Research, Hamilton Health Sciences Centre None None None None None None None
Consultant
Andrew H. Travers Emergency Health Services, Nova Scotia None None None None None American Heart Association† None
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.

†Significant.